Safe delivery of a highly toxic anthracycline derivative through liposomal nanoformulation achieves complete cancer regression

Liposomal formulations of extremely cytotoxic anthracycline analogs, such as LiPyDau, represent a promising and highly effective therapeutic approach for combating drug resistant cancer.

Authors

Institutions

Publication Details

Journal
Molecular Cancer
Published
2025-10-27
DOI
https://doi.org/10.1186/s12943-025-02444-1
Citations
3
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
1.79

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safe delivery of a highly toxic anthracycline derivative through liposomal nanoformulation achieves complete cancer regression

Balázs Gombos, Zoltán Varga, Péter Pokreisz, Gergő Barta et al.
3 citations
Molecular Cancer
Nanoparticle-Based Drug Delivery
1.79
article

Safe delivery of a highly toxic anthracycline derivative through liposomal nanoformulation achieves complete cancer regression

Balázs Gombos, Zoltán Varga, Péter Pokreisz, Gergő Barta, Szilárd Tóth, Kristóf Hegedüs, Eszter Bajtai, Mihály Cserepes, Csaba Magyar, Gergely Szakács, Anikó Gaál, Zsuzsanna Helyes, Agnes Csiszar, Lívia Naszályi Nagy, Sandra Högler, Pál Tamás Szabó, Lukas Kenner, James Cowles, Dávid Szüts, Krisztina Kiss, András Füredi, Zoltán Szeltner, József Tóvári, Gábor Mező, Dániel Kiss, Kata Bölcskei, Attila Kiss
article en
3 citations

Abstract

Liposomal formulations of extremely cytotoxic anthracycline analogs, such as LiPyDau, represent a promising and highly effective therapeutic approach for combating drug resistant cancer.

Molecular CancerVol. 24(1)
Semmelweis University (HU), Obuda University (HU), Eötvös Loránd University (HU), Hungarian Central Statistical Office (HU), University of Veterinary Medicine Vienna (AT), Budapest University of Technology and Economics (HU), Comprehensive Cancer Center Vienna (AT), Institute of Materials and Environmental Chemistry (HU), National Institute of Oncology (HU), National Research, Development and Innovation Office (HU), National Center for Epidemiology (HU), HUN-REN Centre for Energy Research (HU), Hungarian Academy of Sciences (HU), Medical University of Vienna (AT), University of Pecs (HU), HUN-REN Research Centre for Natural Sciences (HU)
European Commission, Austrian Science Fund, Universität Wien, Medizinische Universität Wien, National Research, Development and Innovation Office, H2020 Marie Skłodowska-Curie Actions
Openalex Percentile: Top 14%
Nanoparticle-Based Drug Delivery
1.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.